Cargando…

Durvalumab: Immune-related pneumonitis: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787610/ http://dx.doi.org/10.1007/s40278-021-88128-1

Ejemplares similares

Acute-Onset Pneumonitis while Administering the First Dose of Durvalumab
por: Tonk, Erwin H.J., et al.
Publicado: (2019)

Durvalumab/elasomeran: Immune thrombocytopenia: case report
Publicado: (2022)

Ipilimumab/nivolumab: Immune-related pneumonitis: 2 case reports
Publicado: (2020)

Development of autoimmune diabetes with severe diabetic ketoacidosis and immune-related thyroiditis secondary to durvalumab: a case report
por: Lopes, Ana Rita, et al.
Publicado: (2020)

Durvalumab: First report of minimal change disease: case report
Publicado: (2022)

Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumab
por: Shaverdian, Narek, et al.
Publicado: (2020)

Durvalumab-Induced Diffuse Alveolar Hemorrhage: An Autopsy Case Report
por: Kanaoka, Kensuke, et al.
Publicado: (2020)

Sintilimab: Pneumonitis: case report
Publicado: (2021)

Amiodarone: Pneumonitis: case report
Publicado: (2021)

Osimertinib: Pneumonitis: case report
Publicado: (2021)

Ibrutinib: Pneumonitis: case report
Publicado: (2021)

Crizotinib: Pneumonitis: case report
Publicado: (2021)

Rifampicin: Pneumonitis: case report
Publicado: (2020)

Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC
por: Kinehara, Yuhei, et al.
Publicado: (2023)

Durvalumab/everolimus: Lung toxicity and pulmonary sarcoidosis: 2 case reports
Publicado: (2021)

Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report
por: Cham, Jason, et al.
Publicado: (2021)

Drug-related pneumonitis with radiographic hypersensitivity pneumonitis pattern: Three case series
por: Nakamura, Yukihiro, et al.
Publicado: (2021)

Drug‐induced immune‐mediated thrombocytopenia secondary to durvalumab use
por: Dougherty, Sean C., et al.
Publicado: (2021)

Durvalumab-induced Immune-related Hepatitis in a Patient with Non-small Cell Lung Cancer
por: Nakamura, Masakatsu, et al.
Publicado: (2020)

Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer
por: Nishimura, Ari, et al.
Publicado: (2021)

Retinal Vasculitis Secondary to Durvalumab
por: R. Andrade, Antonio, et al.
Publicado: (2020)

Methotrexate: Hypersensitivity pneumonitis: case report
Publicado: (2021)

Immunotherapy-induced pneumonitis: cases report
por: Helber, Henrique Alkalay, et al.
Publicado: (2018)

Nivolumab: Interstitial pneumonitis: case report
Publicado: (2020)

Tozinameran: Myopericarditis and pneumonitis: case report
Publicado: (2022)

Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer
por: Inoue, Hiroto, et al.
Publicado: (2020)

Two Cases of Nivolumab Re-Administration after Pneumonitis as Immune-Related Adverse Events
por: Imafuku, Keisuke, et al.
Publicado: (2017)

Myocarditis with tremelimumab plus durvalumab combination therapy for endometrial cancer: A case report
por: Mahmood, Syed S., et al.
Publicado: (2018)

Simultaneous development of pneumonitis and autoimmune diabetes secondary to immune checkpoint inhibitor treatment with durvalumab in an advanced small cell lung cancer patient: A case report
por: Wen, Yan-Ping, et al.
Publicado: (2022)

Pembrolizumab: Interstitial bilateral pneumonitis: case report
Publicado: (2021)

Ipilimumab/nivolumab: Diffuse pneumonitis: case report
Publicado: (2020)

Tozinameran: Vaccine-induced pneumonitis: case report
Publicado: (2022)

Daptomycin: Acute eosinophilic pneumonitis: case report
Publicado: (2022)

Tozinameran: Interstitial pneumonitis: 3 case reports
Publicado: (2022)

Tozinameran: Radiation recall pneumonitis: case report
Publicado: (2022)

Early amiodarone pneumonitis: A case report
por: Soleimani, Abbas, et al.
Publicado: (2022)

Flecainide-induced pneumonitis: a case report
por: Moureau, Gauthier, et al.
Publicado: (2022)

Severe immune‐related hyperthermia followed by immune‐related pneumonitis with PD‐1 inhibitor (sintilimab) in small cell lung cancer: A case report
por: Li, Yi‐hui, et al.
Publicado: (2021)

Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan
por: Oshiro, Yoshiko, et al.
Publicado: (2021)

Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer
por: Hassanzadeh, Comron, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i0re240003m1a083m6sl2gvufk